Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holly M Nguyen

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2018
A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic ScreeningMichael L Beshiri, Caitlin M Tice, Crystal Tran, et al.
European Urology|June 23, 2019
Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multifaceted Growth Suppression and Impaired DNA Damage Response Transcriptomic Program in Patient-derived XenograftsHung-Ming Lam, Holly M Nguyen, Mark P Labrecque, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2016
Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived XenograftsHung-Ming Lam, Ryan McMullin, Holly M Nguyen, et al.
The Prostate|October 5, 2023
Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancerMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Molecular Oncology|January 15, 2024
Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosisTatsuo Sugawara, Ekaterina Nevedomskaya, Simon Heller, et al.
The American Journal of Pathology|June 28, 2011
Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinasesAaron P Putzke, Aviva P Ventura, Alexander M Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2019
Identification of Therapeutic Vulnerabilities in Small-cell Neuroendocrine Prostate CancerAlexandra N Corella, Ma Victoria Andrea Cabiliza Ordonio, Ilsa Coleman, et al.
Oncogene|August 15, 2019
Circular RNAs add diversity to androgen receptor isoform repertoire in castration-resistant prostate cancerSubing Cao, Tianfang Ma, Nathan Ungerleider, et al.
The Journal of Clinical Investigation|June 24, 2025
BET inhibitors reduce tumor growth in preclinical models of gastrointestinal gene signature-positive castration-resistant prostate cancerShipra Shukla, Dan Li, Woo Hyun Cho, et al.
Cancer Research|July 27, 2021
RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate CancerMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2018
A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic ScreeningMichael L Beshiri, Caitlin M Tice, Crystal Tran, et al.
European Urology|June 23, 2019
Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multifaceted Growth Suppression and Impaired DNA Damage Response Transcriptomic Program in Patient-derived XenograftsHung-Ming Lam, Holly M Nguyen, Mark P Labrecque, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2016
Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived XenograftsHung-Ming Lam, Ryan McMullin, Holly M Nguyen, et al.
The Prostate|October 5, 2023
Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancerMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Molecular Oncology|January 15, 2024
Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosisTatsuo Sugawara, Ekaterina Nevedomskaya, Simon Heller, et al.
The American Journal of Pathology|June 28, 2011
Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinasesAaron P Putzke, Aviva P Ventura, Alexander M Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2019
Identification of Therapeutic Vulnerabilities in Small-cell Neuroendocrine Prostate CancerAlexandra N Corella, Ma Victoria Andrea Cabiliza Ordonio, Ilsa Coleman, et al.
Oncogene|August 15, 2019
Circular RNAs add diversity to androgen receptor isoform repertoire in castration-resistant prostate cancerSubing Cao, Tianfang Ma, Nathan Ungerleider, et al.
The Journal of Clinical Investigation|June 24, 2025
BET inhibitors reduce tumor growth in preclinical models of gastrointestinal gene signature-positive castration-resistant prostate cancerShipra Shukla, Dan Li, Woo Hyun Cho, et al.
Cancer Research|July 27, 2021
RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate CancerMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Pageof 5